Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 9 clinical trials
featured
Are you a type 2 diabetic between 30 and 70 years of age and currently being treated with either Metformin alone or Metformin in combination with Sulfonylurea such as Glyburide (Diabeta), Glipizide (Glucotrol), Repaglinide (Prandin)?

Are you a type 2 diabetic between 30 and 70 years of age and currently being treated with either Metformin alone or Metformin in combination with Sulfonylurea such as Glyburide (Diabeta), Glipizide

  • 94 views
  • 08 Nov, 2020
  • 1 location
featured
Do you have Type 2 Diabetes? We are enrolling adult volunteers now.

Do you have Type 2 Diabetes? We are enrolling adult volunteers now.

  • 18 views
  • 25 Mar, 2021
  • 1 location
featured
Diabetes /Adolescent Type 2 diabetes.

Diabetes /Adolescent Type 2 diabetes.

  • 74 views
  • 08 Nov, 2020
  • 1 location
The Effect of Sitagliptin on Hypertension Arterial Stiffness Oxidative Stress and Inflammation

Recently a new category of antihyperglycemic therapy aiming to modulate the incretin system has emerged. These drugs induce insulin secretion without inducing hypoglycemia. The effect of the incretin modulators drugs on hypertension, arterial stiffness, inflammation and oxidative stress parameters have not been fully investigated yet.GLP-1 analogue has been suggested to …

heart disease
glucagon-like peptide 1
type 2 diabetes mellitus
sitagliptin
arterial stiffness
  • 11 views
  • 07 Nov, 2020
  • 1 location
Effect of Pioglitazone on T2DM Patients With COVID-19

Approximately 10-15% of patients infected with COVID-19 develop severe illness characterized by respiratory distress, increased risk of clotting disease, myocardial damage, stroke and mortality. Subjects with Type 2 diabetes (T2DM) are at increased risk for severe COVID-19 disease. Exuberant inflammatory and immune responses were suggested as the etiology responsible for …

  • 0 views
  • 25 Mar, 2021
  • 5 locations
Efficacy of Ipragliflozin Compared With Sitagliptin in Uncontrolled Type 2 Diabetes With Sulfonylurea and Metformin

is 7.5% with sulfonylurea and metformin, 2) to investigate changes of other metabolic and cardiovascular risk factors such as triglyceride, HDL-cholesterol, uric acid, blood pressure, and

glimepiride
sitagliptin
gliclazide
sitagliptin 100 mg
sulfonylurea
  • 8 views
  • 08 Apr, 2021
  • 1 location
Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease

The primary aim is to establish the safety, efficacy and mechanism of action of lanifibranor in patients with type 2 diabetes (T2DM) and nonalcoholic fatty liver disease (NAFLD). Specifically, to determine if lanifibranor decreases intrahepatic triglycerides (IHTG) (primary endpoint), improves hepatic insulin sensitivity, endogenous (hepatic) glucose production, de novo lipogenesis …

insulin sensitivity
neutrophil count
conjugated bilirubin
type 2 diabetes mellitus
diabetes
  • 13 views
  • 31 Mar, 2021
  • 1 location
Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment

females who are new users of antidiabetic drugs (ADs) in classes other than sodium-glucose cotransporter 2 (SGLT2) inhibitors, insulin monotherapy, metformin monotherapy, or sulfonylurea monotherapy and

bladder cancer
bladder tumor
metformin
cancer
  • 0 views
  • 21 May, 2021
  • 4 locations
Substitution of Sulfonylureas With New Generation of Hypoglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus

This is a multicentric, prospective, parallel groups study. Patient recruitment will be carried out at the U.O. Departmental Endocrinology and Diabetology ASST FBF Sacco, Fatebenefratelli and Ophthalmic Hospital, and at the SSD of Endocrine Diseases and Diabetology ASST FBF Sacco, L. Sacco Hospital. At the screening visit, patients being treated …

diabetes
renal function
active treatment
  • 0 views
  • 26 Jan, 2021
  • 1 location